MCRB   $8.81  -4.96% Market Closed

Seres Therapeutics, Inc.
Total Cash 71.23M
totalCashPerShare 0.469
EBITDA -151.58M
Total Debt 212.62M
quickRatio 0.83
currentRatio 1.378
Total Revenue 374.00K
debtToEquity
Revenue/Share 0.003
ROA -0.27102
ROE
grossProfits
freeCashflow -98.53M
operatingCashflow -181.80M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -422.1123
profitMargins 0.0
enterpriseValue 264.58M
forwardPE -1.4399999
floatShares 110.83M
sharesOutstanding 170.20M
sharesShort 18.05M
sharesShortPriorMonth 17.22M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.41%
Short Ratio help_outline 3.48%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue -0.574
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -162.10M
trailingEps -1.19%
forwardEps -0.55%
enterpriseToEbitda -1.75
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.24 3Q 2024
institutionsCount 109
lastUpdated Nov. 6, 2024, 6:30 p.m.